Target intelligence / Profile preview

Voltage-dependent anion-selective channel 2 (VDAC2) and Voltage-dependent anion-selective channel 3 (VDAC3) (VDAC2, VDAC3)

Target
VDAC2, VDAC3
Molecular classification
Ion channel, Transporter, Outer mitochondrial membrane porin
01

Overview

Voltage-dependent anion-selective channel 2 and 3 are mitochondrial outer membrane proteins belonging to the porin family. **VDAC2** shares many functions with other VDAC isoforms but is distinguished by its prominent role in facilitating mitochondrial calcium uptake, modulating apoptosis through regulation of Bak, and unique structural motifs (notably a longer N-terminal sequence and additional cysteine residues) that may be important for isoform-specific roles[5][6]. **VDAC3**, though highly homologous in structure to VDAC1 and VDAC2, demonstrates less abundant expression, unique electrophysiological properties (smaller, less voltage-gated conductance), and a prominent role in sperm flagellum organization and centrosome function, as well as sensing the oxidative state in mitochondria via redox-sensitive cysteine residues[4][1][8][2]. Both VDAC2 and VDAC3 serve as metabolic and apoptotic gatekeepers at the mitochondrial outer membrane by controlling ionic and metabolic flux, interacting with essential cell death proteins, and contributing to cellular energetic homeostasis and stress responses[3][5][4].

Other names
VDAC2: Voltage-dependent anion channel 2VDAC3: Voltage-dependent anion channel 3Outer mitochondrial membrane pore protein (OMMPP2/3)Porin 2/3
02

Mechanism of action

Induction of mitochondrial outer membrane permeabilization (MOMP) via interaction with pro-apoptotic Bcl-2 family proteins (e.g., Bak–VDAC2 interaction regulates Bak activation and apoptosis)[6]. Blockage of VDAC pore by interacting proteins (e.g., hexokinase, tubulin) to regulate metabolite flow and cell survival[3][9]. Modulation of channel gating by redox modifications or binding partners (VDAC3)[8].

03

Biological functions

Transport of ions and metabolites across the mitochondrial outer membrane[3][4][5]Regulation of mitochondrial permeability transition pore (MPTP) formation and cytochrome C release[4][5]Apoptosis regulation (by modulating Bcl-2 family protein activity and cytochrome C release)[4][5][6]Calcium ion (Ca²⁺) homeostasis and signaling[5]Control of oxidative metabolism (ATP/ADP, pyruvate, and other metabolite flux)[3][5]Redox regulation and control of reactive oxygen species (particularly VDAC3)[5][8]Sperm flagellar assembly and centrosome function (VDAC3 specific)[4]
04

Disease associations

Cancer (via apoptosis dysregulation)[5][6]Neurodegenerative diseases (mitochondrial dysfunction)[5]Cardiovascular disease (apoptosis, mitochondrial calcium transport dysregulation)[5]Male infertility (defective sperm flagellar structure/function, for VDAC3)[4]Other mitochondrial dysfunction states
05

Safety considerations

VDACs are essential for cell survival and energy metabolism; pharmacological inhibition can cause cell death in normal tissues, leading to off-target toxicity[5]Manipulation of mitochondrial membrane permeability can result in uncontrolled apoptosis or necrosis[5][6]
06

Interacting drugs

No approved drugs are highly specific for VDAC2 or VDAC3; however, several small molecules and experimental compounds modulate VDAC activity (e.g., erastin, VDAC1/2-targeting peptides)[5]

1 more in the full profile.

07

Biomarkers

VDAC (VDAC1/2/3) protein or mRNA levels as surrogate markers of mitochondrial mass and dysfunction in some diseases[5]VDAC3 localization in sperm as a biomarker for sperm flagellar defects/infertility[4]

Beyond the preview

Go deeper on Voltage-dependent anion-selective channel 2 (VDAC2) and Voltage-dependent anion-selective channel 3 (VDAC3) (VDAC2, VDAC3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-dependent anion-selective channel 2 (VDAC2) and Voltage-dependent anion-selective channel 3 (VDAC3) (VDAC2, VDAC3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call